Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asbill

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Pharmaceutical Science & Technology Today|January 19, 2000
Percutaneous penetration enhancers: local versus transdermal activityAsbill, Michniak
International Journal of Pharmaceutical Compounding|May 17, 2026
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding FacilitiesHayden R Asbill, W Mark Moore, Scott Asbill
Pharmaceutical Science & Technology Today|December 16, 2000
Transdermal testing: practical aspects and methodsEl-Kattan, Asbill, Haidar
International Journal of Pharmaceutical Compounding|August 23, 2013
The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogelJohn J Arnold, Scott Asbill
International Journal of Pharmaceutical Compounding|April 25, 2015
Skin permeation and antinociception of topical gabapentin formulationsEvan Bryson, Scott Asbill, Sarah Sweitzer
Innovations in Pharmacy|October 28, 2022
Traditional Lecture versus Case-Based Learning in a Therapeutic Drug Monitoring Course within an Integrated Pharmacy CurriculumRiley D Bowers, C Scott Asbill
Antimicrobial Agents and Chemotherapy|August 12, 2015
Naegleria fowleri: pathogenesis, diagnosis, and treatment optionsEddie Grace, Scott Asbill, Kris Virga
Hospital Practice (Office Ed.)|December 15, 1990
Progressive back pain and leg weaknessM C Asbill, R B Shey
European Journal of Applied Physiology|November 22, 2023
Effect of cross-slope angle on running economy and gait characteristics at moderate running velocityDavid J Elmer, Henry W Asbill
International Journal of Pharmaceutical Compounding|April 25, 2015
In vitro skin penetration and skin content of progesterone from various topical formulationsAllie Heustess, Scott Asbill, David Eagerton, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pharmaceutical Science & Technology Today|January 19, 2000
Percutaneous penetration enhancers: local versus transdermal activityAsbill, Michniak
International Journal of Pharmaceutical Compounding|May 17, 2026
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding FacilitiesHayden R Asbill, W Mark Moore, Scott Asbill
Pharmaceutical Science & Technology Today|December 16, 2000
Transdermal testing: practical aspects and methodsEl-Kattan, Asbill, Haidar
International Journal of Pharmaceutical Compounding|August 23, 2013
The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogelJohn J Arnold, Scott Asbill
International Journal of Pharmaceutical Compounding|April 25, 2015
Skin permeation and antinociception of topical gabapentin formulationsEvan Bryson, Scott Asbill, Sarah Sweitzer
Innovations in Pharmacy|October 28, 2022
Traditional Lecture versus Case-Based Learning in a Therapeutic Drug Monitoring Course within an Integrated Pharmacy CurriculumRiley D Bowers, C Scott Asbill
Antimicrobial Agents and Chemotherapy|August 12, 2015
Naegleria fowleri: pathogenesis, diagnosis, and treatment optionsEddie Grace, Scott Asbill, Kris Virga
Hospital Practice (Office Ed.)|December 15, 1990
Progressive back pain and leg weaknessM C Asbill, R B Shey
European Journal of Applied Physiology|November 22, 2023
Effect of cross-slope angle on running economy and gait characteristics at moderate running velocityDavid J Elmer, Henry W Asbill
International Journal of Pharmaceutical Compounding|April 25, 2015
In vitro skin penetration and skin content of progesterone from various topical formulationsAllie Heustess, Scott Asbill, David Eagerton, et al.
Pageof 4